Advertisement

Topics

FDA names drugmakers likely blocking access to drug samples

11:33 EDT 17 May 2018 | Reuters

(Reuters) - The U.S. Food and Drug Administration on Thursday listed drugmakers, including Celgene Corp, Mylan NV, Gilead Sciences and Novartis AG, who the regulator says are potentially blocking access to samples of their drugs to delay generic comp...

Original Article: FDA names drugmakers likely blocking access to drug samples

NEXT ARTICLE

More From BioPortfolio on "FDA names drugmakers likely blocking access to drug samples"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...